Inflammation and insulin resistance can trigger metabolic disorders that activate inflammatory transcription factor nuclear factor-κB (NF-κB) and the inflammatory signaling system, as well as elevated cytokine levels, thus accelerating damage to endothelial cell function and formation of atherosclerotic plaques. The gene discussed is NFKB1; the disease is metabolic disease.